Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions

1977 ◽  
Vol 34 (9) ◽  
pp. 931-936
Author(s):  
Bette S. Bennett ◽  
Arthur G. Lipman
Keyword(s):  
Comparative Study ◽  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Prospective Surveillance ◽  
Voluntary Reporting

Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database

2010 ◽  
Vol 25 (12) ◽  
pp. 1876-1880 ◽  
Author(s):  
Santiago Perez-Lloret ◽  
Emmanuelle Bondon-Guitton ◽  
Olivier Rascol ◽  
Jean-Louis Montastruc ◽  
Keyword(s):  
Comparative Study ◽  
Adverse Drug Reactions ◽  
Dopamine Agonists ◽  
Drug Reactions ◽  
Pharmacovigilance Database

Voluntary reporting of adverse drug reactions in a Korean hospital

2007 ◽  
Vol 64 (14) ◽  
pp. 1469-1469 ◽  
Author(s):  
Hye-Young Youn ◽  
Hyun-Jin Kim ◽  
Hyen-Oh La
Keyword(s):  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Voluntary Reporting

A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006

2011 ◽  
Vol 21 (3) ◽  
pp. 285-288 ◽  
Author(s):  
Agnès Sommet ◽  
Genevieve Durrieu ◽  
Maryse Lapeyre-Mestre ◽  
Jean-Louis Montastruc ◽  
Keyword(s):  
Comparative Study ◽  
Adverse Drug Reactions ◽  
Heat Waves ◽  
Drug Reactions

Comparative Study of Incadronate and Elcatonin in Patients with Malignancy-Associated Hypercalcaemia

2002 ◽  
Vol 30 (3) ◽  
pp. 230-243 ◽  
Author(s):  
T Matsumoto ◽  
N Nagata ◽  
N Horikoshi ◽  
I Adachi ◽  
Y Ohashi ◽  
...  
Keyword(s):  
Comparative Study ◽  
Adverse Drug Reactions ◽  
Serum Calcium ◽  
Intravenous Infusion ◽  
Rapid Onset ◽  
Clinical Usefulness ◽  
Efficacy And Safety ◽  
Drug Reactions ◽  
Intramuscular Injections ◽  
Disturbance Of Consciousness

The clinical usefulness of incadronate was compared with elcatonin in 26 patients with malignancy-associated hypercalcaemia. Data from 21 and 24 patients could be used to assess efficacy and safety, respectively. Eleven patients were given a single 10-mg intravenous infusion of incadronate and 10 received twice-daily intramuscular injections of 40 IU of elcatonin for 7 consecutive days. After treatment, corrected serum calcium levels decreased significantly in both groups. The anti-hypercalcaemic effect of elcatonin was characterized by its rapid onset, with serum calcium levels reduced 1 day after administration. In contrast, the anti-hypercalcaemic effect of incadronate was more sustained but only became apparent a few days after infusion. Evaluation of symptoms revealed significantly greater improvement rates in the incadronate group compared with the elcatonin group. Adverse drug reactions were observed in three patients in the incadronate group, i.e. mild and transient fever in two cases and exacerbation of disturbance of consciousness in one case. These findings suggest that incadronate produces more marked and sustained hypocalcaemic effects than elcatonin, and that co-administration of these two drugs may yield both rapid and sustained control of malignancy-associated hypercalcaemia.

A comparative study of adverse drug reactions reported through hospital and private medicine

1996 ◽  
Vol 41 (2) ◽  
pp. 166-168 ◽  
Author(s):  
J. P. LEMOZIT ◽  
G. PETIT DE LA RHODIERE ◽  
M. LAPEYRE-MESTRE ◽  
H. BAGHERI ◽  
J. L. MONTASTRUC
Keyword(s):  
Comparative Study ◽  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Private Medicine
Sign in / Sign up

Export Citation Format

Share Document